Cathay Biotech (SHSE:688065) Total Stockholders Equity : ¥11,253 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Total Stockholders Equity?

Cathay Biotech's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥11,253 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cathay Biotech's Book Value per Share for the quarter that ended in Mar. 2024 was ¥19.29. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cathay Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.15.

Cathay Biotech Total Stockholders Equity Historical Data

The historical data trend for Cathay Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Total Stockholders Equity Chart

Cathay Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

4,641.86

10,384.74

10,651.92

10,948.96

11,164.18

Cathay Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															11,010.59	11,082.09	11,137.78	11,164.18	11,253.24

Cathay Biotech (SHSE:688065) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cathay Biotech's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(11253.239	-	0)	/	583.378
	=	19.29

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cathay Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1085.27	+	597.589)	/	11253.239
	=	0.15

Cathay Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cathay Biotech (SHSE:688065) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

https://www.cathaybiotech.com

Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines